Evidence Over Expense - The Real ROI: What Happens After the Sale?

The UV technology has been purchased, delivered, and rolled into the facility. So now what? In the final episode of "Evidence Over Expense," Kyle Morrison and Xenex's Selena Pfannstiel join us to explore why the real return on investment begins after the sale is complete. From staff training and user adoption to reporting, accountability, workflow integration, and ongoing vendor support, this conversation breaks down the often-overlooked factors that can make or break long-term program success. If your organization is investing in UV technology to reduce transmission risk and drive lasting value, this episode will change the way you think about what happens after the rollout. Tune in to this series finale today! Once you complete the interview, jump on over to the link below to take a short quiz and download your CEC certificate for 0.5 CECs! – https://www.flexiquiz.com/SC/N/ps-xenex-ep3 A special thanks to our sponsor, Xenex, for making this series possible. #PowerSupply #Xenex #HealthcareSupplyChain #InfectionPrevention #ValueAnalysis #EvidenceOverExpense #UVTechnology #Podcast